AAS that have a high potential for aromatization like testosterone and particularly methyltestosterone show a high risk of gynecomastia at sufficiently high dosages, while AAS that have a reduced potential for aromatization like nandrolone show a much lower risk (though still potentially significant at high dosages). The capacity to be metabolized by 5α-reductase and the AR activity of the resultant metabolites appears to be one of the major, if not the most important determinant of the androgenic–myotrophic ratio for a given AAS. AR agonists are antigonadotropic – that is, they dose-dependently suppress gonadal testosterone production and hence reduce systemic testosterone concentrations. Moreover, CAIS women have lean body mass that is normal for females but is of course greatly reduced relative to males. May have additive effects with CNS depressants e.g. hypnotics, sedatives, tranquilizers, antianxiety agents. Overdosage with cyproheptadine is likely to result in significant sedation - although paradoxical stimulation has been noted in pediatric patients - and anticholinergic adverse effects such as dry mouth and flushing. The reason for its efficacy in preventing anaphylactic shock has not been elucidated, but appears to be related to its anti-serotonergic effects. It competes with histamine for H1-receptor sites on effector cells in the GI tract, blood vessels and resp tract. As such, the distinction between the terms anabolic steroid and androgen is questionable, and this is the basis for the revised and more recent term anabolic–androgenic steroid (AAS). (Likewise, all "androgens" are inherently anabolic.) Indeed, it is likely impossible to fully dissociate anabolic effects from androgenic effects, as both types of effects are mediated by the same signaling receptor, the AR. With these developments, anabolic steroid became the preferred term to refer to such steroids (over "androgen"), and entered widespread use. It was the first steroid with a marked and favorable separation of anabolic and androgenic effect to be discovered, and has accordingly been described as the "first anabolic steroid". Subsequently, in 1955, it was re-examined for testosterone-like activity in animals and was found to have similar anabolic activity to testosterone, but only one-sixteenth of its androgenic potency. Consequently, exogenously administered AAS will also exert negative feedback, thereby suppressing testicular testosterone production and spermatogenesis. LH stimulates testosterone production and, in conjunction with FSH, regulates spermatogenesis. The testicular production of testosterone is governed by the hypothalamic–pituitary–gonadal axis (HPGA; see Figure 5). Creatine is also used as a dietary supplement to increase muscle creatine stores (162). Do not use Anabol in larger or smaller amounts or for longer than recommended. Anabol is used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes/nose, sneezing, hives, and itching. Anabol is a first-generation antihistamine with additional anticholinergic, antiserotonergic, and local anesthetic properties. Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities. MAOIs prolong and intensify the anticholinergic effects of antihistamines. In an uncontrolled multicenter contraceptive efficacy study, 271 men received 200 mg testosterone enanthate weekly for a minimum of 6 months (202). More specifically, gynecomastia results from an absolute or relative deficiency of androgenic, or absolute or relative excess of estrogenic, action on breast tissue. The root cause of gynecomastia is hormonal, resulting from an imbalance of androgenic and estrogenic action on breast tissue (201). Not uncommonly in this time period, dissatisfaction with the intercourse, frustration of the sexual relationship with the bed partner(s), and loss of self-confidence may lead to perpetuation of erectile dysfunction even when testosterone levels recover. Three months after ceasing AAS use and 1 year after the start of the AAS cycle it was reported by 14% and 1% of users, respectively. Stanozolol binds to androgen receptors, such as membrane bound receptor proteins LAGS and stanozolol-binding protein (STBP). All identified metabolites are hydroxylated, namely at C-3' of the pyrazole ring and at C-4 beta, C-16 alpha and C-16 beta of the steroid. (See all compounds classified as Anabolic Agents.) They stimulate the development of muscle mass, strength, and power. These compounds stimulate anabolism and inhibit catabolism. Therefore, it should not be assumed that an AAS-induced decrease in Lp(a) might negate the other effects that are detrimental to cardiovascular health. In a double-blind trial, nandrolone decanoate (200 mg weekly) for 8 weeks decreased Lp(a) compared with baseline, but not compared with placebo, in a group of bodybuilders (124). In contrast, cross-sectional research demonstrated impaired CEC in AAS users compared with age-matched, strength-trained nonusers and sedentary controls (139). Regardless of the mechanism of action, it is uncertain how an AAS-induced decrease in HDL-cholesterol might affect CVD risk. The decrease was less than that of 2 control subjects in the same study who experienced a reduction of 49%. In the HAARLEM study, HDL-cholesterol decreased by 0.4 mmol/L during use and returned to baseline 3 months after cessation of use. Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. Anabol works by blocking the action of histamine, a substance in the body that causes allergic symptoms. A single study examining the difference in absorption of orally administered versus sublingually administered cyproheptadine in five healthy males demonstrated a mean Cmax of 30.0 mcg/L and 4.0 mcg/L, respectively, and a mean AUC of 209 mcg.h/L and 25 mcg.h/L, respectively. Patient with CV disease including HTN and ischaemic heart disease, increased intraocular pressure, asthma or other chronic breathing disorders, thyroid dysfunction. Anabol appears to exert its antihistamine and antiserotonin effects by competing with free histamine and serotonin for binding at their respective receptors.
